SRTS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SRTS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Sensus Healthcare's Total Liabilities for the quarter that ended in Dec. 2024 was $6.34 Mil. Sensus Healthcare's Total Assets for the quarter that ended in Dec. 2024 was $62.17 Mil. Therefore, Sensus Healthcare's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2024 was 0.10.
The historical data trend for Sensus Healthcare's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sensus Healthcare Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Liabilities-to-Assets | Get a 7-Day Free Trial |
![]() |
![]() |
0.23 | 0.19 | 0.15 | 0.09 | 0.10 |
Sensus Healthcare Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Liabilities-to-Assets | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.09 | 0.11 | 0.09 | 0.10 | 0.10 |
For the Medical Devices subindustry, Sensus Healthcare's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Sensus Healthcare's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Sensus Healthcare's Liabilities-to-Assets falls into.
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Sensus Healthcare's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2024 is calculated as:
Liabilities-to-Assets (A: Dec. 2024 ) | = | Total Liabilities | / | Total Assets |
= | 6.338 | / | 62.165 | |
= | 0.10 |
Sensus Healthcare's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2024 is calculated as
Liabilities-to-Assets (Q: Dec. 2024 ) | = | Total Liabilities | / | Total Assets |
= | 6.338 | / | 62.165 | |
= | 0.10 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sensus Healthcare (NAS:SRTS) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Thank you for viewing the detailed overview of Sensus Healthcare's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael Sardano | officer: GENERAL COUNSEL | 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487 |
Javier Rampolla | officer: Chief Financial Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
John Heinrich | director | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Joseph C Sardano | director, officer: Chief Executive Officer | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Samuel O'rear | director | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Magdalena Martinez | officer: Chief Operating Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Emiliano Sosa | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
William H Mccall | director | 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487 |
Nicolas Soro | officer: Chief Operating Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
Stephen Brad Cohen | officer: EXECUTIVE VICE PRESIDENT | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Megan Cornish | director | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Yonatan Vainer | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Russ Price | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
Kalman Fishman | officer: CHIEF TECHNOLOGY OFFICER | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Richard Golin | officer: EXECUTIVE VICE PRESIDENT | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
From GuruFocus
By GuruFocus News • 02-05-2025
By GlobeNewswire • 11-18-2024
By Marketwired • 10-31-2024
By Business Wire • 03-13-2025
By Marketwired • 11-18-2024
By Business Wire • 01-23-2025
By Marketwired • 09-25-2024
By GuruFocus News • 02-06-2025
By Marketwired • 08-01-2024
By GuruFocus News • 11-15-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.